Skip to main content
Premium Trial:

Request an Annual Quote

Shimadzu Establishes Latin American Subsidiary

NEW YORK (GenomeWeb News) – Shimadzu today announced the creation of a wholly owned subsidiary in Uruguay to bolster its Central and South American business.

Shimadzu Latin America (SLA) will serve as Shimadzu's base in the region. Shimadzu do Brasil Comercio (SBL) in Sao Paulo was created in 1997 and had been coordinating Shimadzu's operations in Central and South America. As SBL's business within Brazil grew and Brazilian regulations limited SBL's trading activities with its neighbors, Shimadzu chose to create SLA, it said.

Uruguay "has free trade zones where foreign-capital organizations can establish a company easily, companies can have bonded warehouses, and the degree of financial freedom is high as compared to surrounding countries," Kyoto, Japan-based Shimadzu said.

In the spring, the company created a wholly owned sales company in Taiwan to expand its footprint there.

Filed under

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.